Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, Fraile G, Montalbán C. Salar A, et al. Among authors: servitje o. Cancer. 2009 Nov 15;115(22):5210-7. doi: 10.1002/cncr.24605. Cancer. 2009. PMID: 19672998 Free article. Clinical Trial.
Langerhans cell sarcoma: Response to radiotherapy.
Lucas A, Barca EG, Servitje O, Abenoza L, González MN, Macià M, Lozano A. Lucas A, et al. Among authors: servitje o. Rep Pract Oncol Radiother. 2010 Jul 6;15(4):107-9. doi: 10.1016/j.rpor.2010.05.001. eCollection 2010. Rep Pract Oncol Radiother. 2010. PMID: 24376934 Free PMC article.
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.
Muniesa C, Domingo-Domenech E, Fornons-Servent R, Peñate Y, Estrach MT, Ramón MD, Medina S, Flórez Á, Ortiz-Romero PL, Sánchez-Caminero MP, Torres-Navarro I, Acebo E, Yanguas I, Fernández-de-Misa R, Blanes M, Zayas A, Descalzo MA, Garcia-Doval I, Servitje O. Muniesa C, et al. Among authors: servitje o. J Am Acad Dermatol. 2020 Nov;83(5):1535-1538. doi: 10.1016/j.jaad.2020.07.028. Epub 2020 Jul 16. J Am Acad Dermatol. 2020. PMID: 32682893 No abstract available.
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.
Peñate Y, Hernández-Machín B, Pérez-Méndez LI, Santiago F, Rosales B, Servitje O, Estrach T, Fernández-Guarino M, Calzado L, Acebo E, Gallardo F, Salar A, Izu R, Ortiz-Romero PL, Pujol RM, Fernández-de-Misa R. Peñate Y, et al. Among authors: servitje o. Br J Dermatol. 2012 Jul;167(1):174-9. doi: 10.1111/j.1365-2133.2012.10902.x. Br J Dermatol. 2012. PMID: 22356294 Clinical Trial.
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.
Muniesa C, Gallardo F, García-Doval I, Estrach MT, Combalia A, Morillo-Andújar M, De la Cruz-Vicente F, Machan S, Moya-Martínez C, Rovira R, Sanchez-Gonzalez B, Acebo E, Amutio E, Peñate Y, Losada-Castillo MDC, García-Muret MP, Iznardo H, Román-Curto C, Cañueto J, Fernández-de-Misa R, Flórez Á, Izu RM, Torres-Navarro I, Zayas A, Pérez-Paredes G, Blanes M, Yanguas JI, Pérez-Ferriols A, Callejas-Charavia M, Ortiz-Romero PL, Pérez-Gil A, Prieto-Torres L, González-Barca E, Servitje O. Muniesa C, et al. Among authors: servitje o. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):57-64. doi: 10.1111/jdv.18563. Epub 2022 Sep 9. J Eur Acad Dermatol Venereol. 2023. PMID: 36017748
100 results